Anthony Walker

Recent Posts

Pharma & Biotech Due Diligence Insight

01st September 2019
For close to fifteen years, Alacrita has been an expert resource for due diligence and valuation services covering pharmaceuticals and biotechnology. This paper shares some of the insights we've...
Learn More

Biotech & Pharma Due Diligence Best Practices, Pitfalls & Checklist

23rd August 2019
For over fifteen years, Alacrita has been an expert resource for due diligence and valuation services covering pharmaceuticals and biotechnology. This paper shares some of the insights we've learned...
Learn More

Leveraging Diagnostics to Realize the Full Potential of Precision Oncology

07th July 2017
As we approach the twentieth anniversary of the approval of Herceptin, the field of precision oncology has never been more exciting or dynamic, and utility seems to be broadly recognized. Precision...
Learn More

Commercialization of Cellular Immunotherapies

07th May 2016
Commercialization of Cellular Therapies Biochemical Society Transactions Apr 11, 2016,44(2)329-332; DOI: 10.1042/BST20150240 Abstract Successful commercialization of a cell therapy requires more than...
Learn More

What's wrong with NPV valuations?

26th October 2015
Risk-adjusted NPV is Notoriously Fallible Over at least the past decade, risk-adjusted Net Present Value (rNPV) has emerged as the de facto standard for valuing pharmaceutical R&D projects (1,2)....
Learn More

Is Manufacturing just ‘bad news’?

15th August 2013
Over the past few months one could have been forgiven for thinking that outsourcing supply to Indian manufacturers was a major problem. The recent spate of FDA Warning Letters, and actions, against...
Learn More

Deal Watch Annual Review 2011

18th January 2012
The Annual Review of deals by the Medius Deal Watch Team can be accessed through the link below.
Learn More

Viewpoint: Pharma Industry Myths

06th January 2012
Amidst the voluminous commentaries, blogs, tweets, panels and papers about the future of the pharma industry, certain thoughts seem to be becoming articles of faith:
Learn More
1

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

© 2009-24 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

Alacrita Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.